NCT00004197: Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma |
|
|
| Completed | 2 | | US | keyhole limpet hemocyanin, sargramostim, tumor cell-based vaccine therapy, cyclophosphamide, Cytoxan, doxorubicin hydrochloride, Lipodox, Lipodox 50, and Doxil, mitoxantrone hydrochloride, Novantrone, prednisone, Prednisone Intensol, Deltasone, Rayos, vincristine sulfate, Kyocristine, Vincrisul, Onkovin | University of Nebraska, National Cancer Institute (NCI) | Lymphoma | 01/02 | 11/03 | | |
NCT00026208: Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma |
|
|
| Completed | 2 | 76 | US | Vincristine, Vinblastine, Leurocristine sulfate, Oncovin, Vincasar, LCR, VCR, Vincristin, Vincristina, Vincristinum, 22-Oxovincaleukoblastin, 22-Oxovincaleukoblastine, Cyclophosphamide, Cytoxan, Neosar, Cyclophosphamidum, Cyclophosphamid, Ciclofosfamida, Cytophosphane, Ledoxina, Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester, 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide, N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide, Doxorubicin, Adriamycin, Doxorubicinum, Doxorubicine, Rubex, Hydroxydaunomycin HCl, Hydroxydoxorubicin HCl, Hydroxydaunorubicin, 14-hydroxydaunomycin, 14-hydroxydaunorubicine, (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, (8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione, Prednisone, Dehydrocortisone, Deltasone, Liquid Pred, Meticorten, Orasone, Prednicot, predniSONE Intensol, Rayos, Sterapred, Prednisona, Prednisonum, 1,2-Dehydrocortisone, 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione, 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione, Bleomycin, Bleomycin A2, Bleomycine, Bleocin, Bleomicin, Bleomicina, Bleomycinum, BLM, Etoposide, Toposar, Etopophos, Vepesid, VP-16, Etoposido, Etoposidum, trans-Etoposide, 4-demethylepipodophyllotoxin β-D-ethylideneglucoside, 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside), 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one, Low-dose radiotherapy (RT) | Stanford University | Lymphoma, Hodgkin Disease, Lymphoma, Hodgkin Disease, Lymphoma: Hodgkin | 04/13 | 02/17 | | |
